Carmen Espejo Selected Research

Natalizumab (Tysabri)

4/2022	Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre.
1/2020	New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.
3/2015	Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carmen Espejo Research Topics

Disease

33	Multiple Sclerosis 12/2023 - 02/2002
14	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 09/2002
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2009
5	Neuroinflammatory Diseases 01/2020 - 10/2006
4	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2013 - 06/2005
1	Seizures (Absence Seizure) 01/2023
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2023
1	Encephalitis (Encephalitis, Rasmussen) 01/2023
1	COVID-19 04/2022
1	Relapsing-Remitting Multiple Sclerosis 12/2021
1	Chronic Progressive Multiple Sclerosis 01/2020
1	Neoplasms (Cancer) 11/2019
1	Infections 01/2019
1	Dysbiosis 01/2019
1	Disease Progression 02/2018
1	Opportunistic Infections (Opportunistic Infection) 03/2015
1	Progressive Multifocal Leukoencephalopathy 03/2015
1	Alzheimer Disease (Alzheimer's Disease) 10/2006
1	Amyloid Plaque 10/2006

Drug/Important Bio-Agent (IBA)

6	Myelin-Oligodendrocyte GlycoproteinIBA 12/2023 - 06/2012
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2009
5	AntibodiesIBA 09/2023 - 01/2007
4	Therapeutic UsesIBA 01/2022 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2005
4	AutoantigensIBA 10/2018 - 05/2009
4	AntigensIBA 10/2018 - 02/2002
3	Oligoclonal BandsIBA 11/2022 - 01/2018
3	Natalizumab (Tysabri)FDA Link 04/2022 - 03/2015
3	Interferon-betaIBA 01/2018 - 02/2009
3	Semaphorins (Semaphorin)IBA 01/2017 - 03/2013
2	Cladribine FDA LinkGeneric 01/2023 - 12/2021
2	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 10/2020 - 01/2019
2	LipidsIBA 01/2020 - 03/2015
2	LipopolysaccharidesIBA 01/2020 - 01/2017
2	Peptides (Polypeptides)IBA 07/2019 - 10/2018
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2019 - 01/2018
2	MetallothioneinIBA 10/2006 - 06/2005
1	AutoantibodiesIBA 01/2023
1	Immunoglobulin G (IgG)IBA 11/2022
1	Immunoglobulins (Immunoglobulin)IBA 11/2022
1	interleukin-21 (interleukin 21)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	2'-deoxyadenosineIBA 12/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	InflammasomesIBA 01/2020
1	PyrinIBA 01/2020
1	Neutralizing AntibodiesIBA 11/2019
1	Ophthalmic Solutions (Eye Drops)IBA 07/2019
1	Retinaldehyde (Retinal)IBA 07/2019
1	Bone Morphogenetic Protein 5IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Guanosine Diphosphate (GDP)IBA 10/2018
1	FucoseIBA 10/2018
1	Peptide LibraryIBA 10/2018
1	HLA-DRB3 Chains (HLA DRB3)IBA 10/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2017
1	CytokinesIBA 10/2017
1	InterleukinsIBA 10/2017
1	Interleukin-23 (Interleukin 23)IBA 10/2017
1	EndotoxinsIBA 01/2017
1	Isoantigens (Alloantigen)IBA 12/2016
1	Semaphorin-3AIBA 02/2016
1	ChitinasesIBA 10/2015
1	Immunoglobulin M (IgM)IBA 03/2015
1	heat-shock protein 70.1IBA 01/2014
1	delta proteinIBA 04/2013
1	LigandsIBA 04/2013
1	Polysaccharides (Glycans)IBA 01/2013
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 09/2012
1	A-Form DNA (A-DNA)IBA 06/2012
1	DNA VaccinesIBA 06/2012
1	VaccinesIBA 06/2012
1	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2012
1	Toll-Like Receptor 4IBA 10/2011
1	InterferonsIBA 10/2011
1	Matrix Metalloproteinases (MMPs)IBA 02/2009
1	AntioxidantsIBA 06/2005
1	Interferon-gamma (Interferon, gamma)IBA 09/2002

Therapy/Procedure

7	Therapeutics 01/2020 - 02/2009
1	Treatment Delay 11/2020
1	Precision Medicine 01/2020
1	Immunotherapy 11/2019
1	Topical Administration 07/2019
1	Transplantation 12/2016
1	Immunomodulation 01/2012